Postmortem T2*- Weighted MRI Imaging of Cortical Iron Reflects Severity of Alzheimer's Disease

Marjolein Bulk1,2,3, Boyd Kenkhuis1,2, Linda M van der Graaf2

  • 1Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.

Insights

Iron-sensitive MRI detects Alzheimer's disease (AD) pathology distribution in the brain. This study found distinct patterns in late-onset AD and early-onset AD, correlating MRI changes with iron accumulation and AD hallmarks.

Area of Science:

  • Neuroimaging
  • Neuropathology
  • Biomarkers

Background:

  • Cortical iron accumulation is linked to Alzheimer's disease (AD) pathology.
  • Iron-based MRI changes may aid in AD diagnosis and staging.
  • Understanding the relationship between MRI contrast and AD pathology is crucial.

Purpose of the Study:

  • To determine the cortical distribution of MRI contrast changes in relation to tau pathology.
  • To investigate if MRI contrast changes reflect underlying AD pathology across different brain lobes.
  • To compare MRI findings between late-onset AD (LOAD) and early-onset AD (EOAD).

Main Methods:

  • Ex vivo high-resolution T2*-weighted MRI on postmortem human cortical tissue.
  • Histopathology analysis of the same cortical samples.
  • Correlation analyses between MRI contrast, iron accumulation, and AD pathological hallmarks.

Main Results:

  • LOAD and EOAD exhibit different distribution patterns of AD pathology and MRI contrast changes.
  • EOAD cases showed more severe MRI contrast changes compared to LOAD.
  • Within each lobe, AD pathology severity correlated with iron accumulation and MRI signal changes.

Conclusions:

  • Iron-sensitive MRI sequences can detect the cortical distribution of AD pathology ex vivo.
  • MRI contrast changes reflect the underlying AD pathology and iron accumulation.
  • Distinct MRI-detectable patterns exist for LOAD and EOAD, suggesting potential for differential diagnosis.

Related Concept Videos

Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...